JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2007; 49:2231-2237, doi:10.1016/j.jacc.2007.02.049 (Published online 24 May 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marcoff, L.
Right arrow Articles by Thompson, P. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Marcoff, L.
Right arrow Articles by Thompson, P. D.

The Role of Coenzyme Q10 in Statin-Associated Myopathy

A Systematic Review

Leo Marcoff, MD* and Paul D. Thompson, MD{dagger},{ddagger},*

* Section of Cardiology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut
{dagger} Hartford Hospital, Hartford, Connecticut
{ddagger} University of Connecticut, Farmington, Connecticut


Figure 1
View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 Products of Mevalonate Pathway Possibly Affected by HMG-CoA Reductase Inhibitors (Statins)

Reprinted with permission from Thompson et al. (2). Copyright American Medical Association ©2003. All rights reserved. HMG-CoA = 3-hydroxy-3-methylglutaryl coenzyme A.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.